Stay updated on AB-106 in Advanced NSCLC with ROS1 Fusion Gene Clinical Trial
Sign up to get notified when there's something new on the AB-106 in Advanced NSCLC with ROS1 Fusion Gene Clinical Trial page.

Latest updates to the AB-106 in Advanced NSCLC with ROS1 Fusion Gene Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedThe Record History shows a new revision, v3.5.3, replacing the previous v3.5.2, indicating an update to the page's release notes for this study record.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedRecord history shows the addition of Revision v3.5.2 and removal of Revision v3.5.0.SummaryDifference0.1%

- Check48 days agoChange DetectedA new site revision entry (Revision: v3.5.0) was added and the previous entry (Revision: v3.4.3) was removed from the record history.SummaryDifference0.1%

- Check63 days agoChange DetectedA new revision v3.4.3 is added and revision v3.4.2 is removed from the history.SummaryDifference0.1%

- Check91 days agoChange DetectedVersion 6 adds core study record sections—Study Design, Study Description, Sponsor/Collaborators, Study Status, and Study Identification (revision: v3.4.2). It also removes the previous government funding notice and the AnHeart Therapeutics reference.SummaryDifference3%

- Check98 days agoChange DetectedA site-wide notice about government funding was added and the site version updated from v3.4.0 to v3.4.1; the study record content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

Stay in the know with updates to AB-106 in Advanced NSCLC with ROS1 Fusion Gene Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AB-106 in Advanced NSCLC with ROS1 Fusion Gene Clinical Trial page.